Omega-3 Supplementation to ADHD Medication in Children

Clinical trial NCT02204410 · COMPLETED

Trial details

NCT number: NCT02204410
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Deficient Emotional Self-Regulation

Start date: 2014-07-01
Primary completion: 2016-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.